92 related articles for article (PubMed ID: 6191205)
1. Anticryptococcal type D antibodies raised in rabbits.
Bhattacharjee AK; Bennett JE; Bundle DR; Glaudemans CP
Mol Immunol; 1983 Apr; 20(4):351-9. PubMed ID: 6191205
[TBL] [Abstract][Full Text] [Related]
2. Capsular polysaccharides of Cryptococcus neoformans.
Bhattacharjee AK; Bennett JE; Glaudemans CP
Rev Infect Dis; 1984; 6(5):619-24. PubMed ID: 6209768
[TBL] [Abstract][Full Text] [Related]
3. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.
Dromer F; Salamero J; Contrepois A; Carbon C; Yeni P
Infect Immun; 1987 Mar; 55(3):742-8. PubMed ID: 3546139
[TBL] [Abstract][Full Text] [Related]
4. The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D.
Bhattacharjee AK; Kwon-Chung KJ; Glaudemans CP
Carbohydr Res; 1979 Aug; 73():183-92. PubMed ID: 113098
[TBL] [Abstract][Full Text] [Related]
5. Capsular reactions of Cryptococcus neoformans with polyspecific and oligospecific polyclonal anticapsular antibodies.
MacGill TC; MacGill RS; Kozel TR
Infect Immun; 2001 Feb; 69(2):1189-91. PubMed ID: 11160020
[TBL] [Abstract][Full Text] [Related]
6. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
Duro RM; Netski D; Thorkildson P; Kozel TR
Clin Diagn Lab Immunol; 2003 Mar; 10(2):252-8. PubMed ID: 12626451
[TBL] [Abstract][Full Text] [Related]
7. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.
Spiropulu C; Eppard RA; Otteson E; Kozel TR
Infect Immun; 1989 Oct; 57(10):3240-2. PubMed ID: 2476401
[TBL] [Abstract][Full Text] [Related]
8. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Cherniak R; Reiss E; Slodki ME; Plattner RD; Blumer SO
Mol Immunol; 1980 Aug; 17(8):1025-32. PubMed ID: 6777664
[No Abstract] [Full Text] [Related]
9. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.
Eckert TF; Kozel TR
Infect Immun; 1987 Aug; 55(8):1895-9. PubMed ID: 2440810
[TBL] [Abstract][Full Text] [Related]
10. [The evaluation of the specific type of capsular polysaccharide of Cryptococcus neoformans as an immunogen and positive-control antigen].
Toraño Peraza GT; Rodríguez Acebo W; Martínez Machín G
Rev Cubana Med Trop; 1998; 50(3):207-8. PubMed ID: 10349445
[TBL] [Abstract][Full Text] [Related]
11. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
Martinez LR; Moussai D; Casadevall A
Infect Immun; 2004 Jun; 72(6):3674-9. PubMed ID: 15155683
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490
[TBL] [Abstract][Full Text] [Related]
13. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.
Schlageter AM; Kozel TR
Infect Immun; 1990 Jun; 58(6):1914-8. PubMed ID: 2187813
[TBL] [Abstract][Full Text] [Related]
14. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
Belay T; Cherniak R
Infect Immun; 1995 May; 63(5):1810-9. PubMed ID: 7537249
[TBL] [Abstract][Full Text] [Related]
15. Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
Cleare W; Mukherjee S; Spitzer ED; Casadevall A
Clin Diagn Lab Immunol; 1994 Nov; 1(6):737-40. PubMed ID: 8556529
[TBL] [Abstract][Full Text] [Related]
16. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
Kozel TR; Follette JL
Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
[TBL] [Abstract][Full Text] [Related]
17. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D.
Ikeda R; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1985; 29(10):981-91. PubMed ID: 3908888
[TBL] [Abstract][Full Text] [Related]
18. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.
Valadon P; Nussbaum G; Boyd LF; Margulies DH; Scharff MD
J Mol Biol; 1996 Aug; 261(1):11-22. PubMed ID: 8760499
[TBL] [Abstract][Full Text] [Related]
19. Benzoquinone activation of Cryptococcus neoformans capsular polysaccharide for construction of an immunoaffinity column.
Kozel TR; Hermerath CA
J Immunol Methods; 1988 Feb; 107(1):53-8. PubMed ID: 3125258
[TBL] [Abstract][Full Text] [Related]
20. Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans.
Kozel TR; Cazin J
Mycopathol Mycol Appl; 1974 Oct; 54(1):21-30. PubMed ID: 4139653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
